Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,136 | 28,356 | 36,399 | 42,739 | 115,077 |
| Marketable Securities | 656,155 | 696,925 | 719,600 | 759,578 | 708,769 |
| Receivables | 1,064 | 700 | 852 | 1,534 | 2,671 |
| TOTAL | $693,757 | $747,159 | $778,842 | $811,975 | $835,324 |
| Non-Current Assets | |||||
| PPE Net | 4,601 | 4,346 | 4,230 | 3,864 | 4,061 |
| Intangibles | 27,190 | 27,190 | 27,190 | 27,190 | 27,190 |
| Other Non-Current Assets | 13,923 | 13,645 | 12,917 | 2,557 | 2,272 |
| TOTAL | $45,714 | $45,181 | $44,337 | $33,611 | $33,523 |
| Total Assets | $739,471 | $792,340 | $823,179 | $845,586 | $868,847 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 942 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,410 | 3,265 | 1,114 | 3,802 | 3,234 |
| Accrued Expenses | 25,456 | 33,842 | 28,204 | 18,594 | 17,536 |
| Other current liabilities | 1,653 | N/A | 1,396 | 3,673 | 3,877 |
| TOTAL | $32,018 | $39,501 | $32,093 | $27,658 | $26,291 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,472 | 5,834 | 5,181 | 4,269 | 3,943 |
| TOTAL | $4,472 | $5,834 | $5,181 | $4,269 | $3,943 |
| Total Liabilities | $36,490 | $45,335 | $37,274 | $31,927 | $30,234 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,394 | 66,384 | 66,344 | 66,288 | 65,911 |
| Common Shares | 66 | 66 | 66 | 66 | 66 |
| Retained earnings | -1,609,020 | -1,555,224 | -1,508,132 | -1,466,011 | -1,430,169 |
| Other shareholders' equity | 3,568 | 3,314 | 5,288 | 1,780 | 2,244 |
| TOTAL | $702,981 | $747,005 | $785,905 | $813,659 | $838,613 |
| Total Liabilities And Equity | $739,471 | $792,340 | $823,179 | $845,586 | $868,847 |